• 1
    Martin-Sanz P, Olmedilla L, Dulin E, Casado M, Callejas NA, Perez-Pena J, Garutti I, et al. Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for the liver function. Liver Transpl 2003; 9: 4048.
  • 2
    Morrow JD, Moore KP, Awad JA, Ravenscraft MD, Marini G, Badr KF, Williams R, et al. Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome. J Lipid Mediat 1993; 6: 417420.
  • 3
    Tsikas D, Junker W, Frölich JC. Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr B 1998; 705: 174176.
  • 4
    Tsikas D, Schubert B, Gutzki FM, Sandmann J, Frölich JC. Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by GC-tandem MS as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B (in press).
  • 5
    Tsikas D, Schwedhelm E, Suchy MT, Niemann J, Gutzki FM, Erpenbeck VJ, Hohlfeld JM, et al. Divergence in urinary 8-iso-PGF (iPF-III, 15-F2t-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF: possible methodological, mechanistic and clinical implications. J Chromatogr B 2003; 794: 237255.
  • 6
    Nijveldt RJ, Teerlink T, Siroen MPC., van Lambalgen AA, Rauwerda JA, van Leeuwen PAM. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Cli Nutr 2003; 22: 1722.
  • 7
    Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572574.
  • 8
    Nijveldt RJ, Teerlink T, van der Hover B, Siroen MPC., Kuik DJ, Rauwerda JA, van Leeuwen PAM. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Cli Nutr 2003; 22: 2330.